Search results for "Gout"
Serum urate level may predict flare risk in patients with gout
Approximately 95% of acute gout episodes requiring treatment occurred in patients who had a serum urate level of at least 6 mg/dL at baseline while 98% occurred in those with a baseline level of at least 5 mg/dL, according to a study using UK Biobank data on 1,773 episodes over a mean follow-up of 8.3 years.
https://immattersacp.org/weekly/archives/2024/02/13/1.htm
13 Feb 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/09/spotlight.htm
1 Sep 2023
SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout
New users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had about half the risk of an ED visit or hospitalization for a gout flare as matched patients taking dipeptidyl peptidase-4 inhibitors, a cohort analysis found.
https://immattersacp.org/weekly/archives/2023/07/25/1.htm
25 Jul 2023
New gout guidelines and 'treat to target'
Guidelines by ACP and by rheumatology societies disagree on the treat-to-target approach to therapy.
https://immattersacp.org/archives/2017/04/gout.htm
1 Apr 2017
Allopurinol not associated with increased mortality in patients with CKD, gout
The findings of a database analysis from the United Kingdom provide reassurance that a treat-to-target strategy has no apparent harmful effect on mortality in patients with gout and chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/01/25/2.htm
25 Jan 2022
Guideline recommends allopurinol as first-line therapy for gout
The American College of Rheumatology noted that the drug is the preferred choice for urate-lowering therapy in all patients, including those with moderate to severe chronic kidney disease.
https://immattersacp.org/weekly/archives/2020/05/19/4.htm
19 May 2020
Statins, gout guidelines fuel debate on best practice
This issue covers the debate about statins guidelines, evidence-based guidelines for gout, and physicians-in-training who face discrimination.
https://immattersacp.org/archives/2017/04/editors.htm
1 Apr 2017
SGLT-2 inhibitors associated with lower risk of gout vs. GLP-1 receptor agonists
In a large, propensity-matched study, adult patients with type 2 diabetes who were newly prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor had a lower rate of incident gout than those newly prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist.
https://immattersacp.org/weekly/archives/2020/01/14/2.htm
14 Jan 2020
Gout flares may precede cardiovascular events
A retrospective study found that gout patients who experienced an acute myocardial infarction or stroke had significantly higher odds of a recent gout flare in the preceding four months than those who did not.
https://immattersacp.org/weekly/archives/2022/08/09/1.htm
9 Aug 2022
Boxed warning added to gout drug, more ARBs recalled
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/04/boxed-warning-added-to-gout-drug-more-arbs-recalled.htm
1 Apr 2019